Diagnosing Drug Allergy: the T is the Key

Recruiting now · Not applicable

Conditions studied: Amoxicillin Allergy

In brief

The goal of this clinical trial is to validate a newly developed test in the diagnosis of patients with amoxicillin allergy (i.e. T-cell activation test). The main questions the study aims to assess are the reliability and applicability of this test. Participants will be asked to visit the hospital 1, 3 or 5 times during which blood is collected and when applicable, allergy skin testing is performed.

Key facts

Study ID

NCT06409884

Run by

University Hospital, Antwerp

People needed

300

Starts

2024-05-21

Expected to finish

2027-09-30

Last updated by the study team

2026-05-14

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants are eligible if they:
• Are ≥ 6 years
• Are capable of informed consent, or if appropriate, participants have an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 18 years of age)
• Have a suspected history of amoxicillin allergy

You may not qualify if…

• Patients who are lacking capacity or do not have an acceptable individual capable to provide informed consent
• Pregnant women
• Breastfeeding women

Where it is running

• Antwerp University Hospital — Edegem, Antwerp, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.